Natera logo

Senior Scientist, Product Development

Natera

San Carlos, CAOnsitePosted 1 day ago$138,100 - $172,600/year
Full TimeSenior LevelResearch & ScientistDiagnostics
Original posting ↗

Summary

Join Natera's Oncology Product Development team as a Senior Scientist focusing on Assay Development. You will design, develop, and validate Next-Generation Sequencing (NGS) and circulating tumor DNA (ctDNA) assays used in liquid biopsy and Minimal Residual Disease (MRD) testing.

Job description

Position Summary

Join Natera's Oncology Product Development team as a Senior Scientist focusing on Assay Development. You will design, develop, and validate Next-Generation Sequencing (NGS) and circulating tumor DNA (ctDNA) assays used in liquid biopsy and Minimal Residual Disease (MRD) testing.

Primary Responsibilities

  • Design and plan feasibility, development, verification, and validation studies under design control using stakeholder input, coordinating efforts to achieve milestones within established timelines
  • Independently execute high-complexity experiments, both manually and using automated liquid handlers
  • Take ownership of challenges, relying on data to root-cause issues and execute actionable solutions
  • Partner directly with automation, engineering, R&D, bioinformatics, and lab operations to develop robust, automated workflows
  • Generate high-quality NGS data, managing library preparation, QC, and sequencing runs while flagging technical effects
  • Deliver data-backed updates on progress and outcomes to technical and non-technical audiences and cross-functional teams
  • Write SOPs, study protocols, reports, and manufacturing/QC documents, maintaining rigorous documentation, sample tracking, and data provenance
  • Lead the integration of automated workflows with digital systems such as LIMS and LabVantage (LV), ensuring data integrity between automation and digital platforms through rigorous integration testing
  • Adapt to evolving science and operational needs, executing tasks that move the work forward without waiting for a finished playbook
  • Travel up to 25% of the time to Austin, TX, and other laboratory sites as needed

Qualifications

  • Ph.D. with 5+ years of industry experience (or 2+ years of postdoctoral research and 3+ years of industry experience), or a Master's degree with 7+ years of industry experience in assay development
  • Deep scientific background in Molecular and Cell Biology, Genomics, Biotechnology, or Biochemistry

Knowledge, Skills, and Abilities

  • Extensive hands-on experience with molecular biology techniques, specifically NGS technologies, DNA extraction, multiplex PCR, hybrid capture, and nucleic acid quantification
  • Direct experience with cell-free DNA, circulating tumor DNA, or liquid biopsy
  • Experience with Laboratory Developed Tests (LDT) product development and validation under CLIA/CAP guidelines is highly desired
  • Experience developing or executing assays on automated liquid handling platforms is highly desirable
  • Proficiency in primary data analysis using tools such as Excel, JMP, or R
  • Manage competing priorities while operating with pace and precision in an evolving scientific environment
  • Clear, direct communication and presentation skills with meticulous attention to detail
  • An outcome-focused ownership mindset with demonstrated success in collaborative and individual projects
  • Demonstrated ability to write clear, precise project plans, study protocols, reports, and SOPs
  • Experience with reagent QC is a plus

Requirements

  • Ph.D. with 5+ years of industry experience (or 2+ years of postdoctoral research and 3+ years of industry experience), or a Master's degree with 7+ years of industry experience in assay development
  • Deep scientific background in Molecular and Cell Biology, Genomics, Biotechnology, or Biochemistry
  • Extensive hands-on experience with molecular biology techniques, specifically NGS technologies, DNA extraction, multiplex PCR, hybrid capture, and nucleic acid quantification
  • Direct experience with cell-free DNA, circulating tumor DNA, or liquid biopsy
  • Experience with Laboratory Developed Tests (LDT) product development and validation under CLIA/CAP guidelines is highly desired
  • Experience developing or executing assays on automated liquid handling platforms is highly desirable
  • Proficiency in primary data analysis using tools such as Excel, JMP, or R
  • Manage competing priorities while operating with pace and precision in an evolving scientific environment
  • Clear, direct communication and presentation skills with meticulous attention to detail
  • An outcome-focused ownership mindset with demonstrated success in collaborative and individual projects
  • Demonstrated ability to write clear, precise project plans, study protocols, reports, and SOPs
  • Experience with reagent QC is a plus

Benefits

  • Annual performance incentive bonus
  • Long-term equity awards
  • Medical, Dental & Vision
  • 401(k) Matching
  • Paid Time Off
  • Company Holidays
  • Free Testing
  • Fertility Care Benefits
  • Pregnancy & Baby Bonding Leave
  • Commuter Benefits
  • Employee Referral Program

Company overview

Natera is a global leader in cell-free DNA (cfDNA) testing, specializing in molecular diagnostics for oncology, women's health, and organ health. Founded in 2004 and headquartered in Austin, Texas, the company has developed a cutting-edge cfDNA technology platform that combines novel molecular biology techniques with bioinformatics software and artificial intelligence. Natera's proprietary technology enables detection down to a single molecule in a tube of blood, making it possible to provide highly accurate genetic testing services. The company's flagship products include Signatera, a personalized circulating tumor DNA test for cancer monitoring; Panorama, a non-invasive prenatal test for chromosomal abnormalities; and Prospera, a transplant rejection assessment test. With over 4,400 employees and operations in CLIA-certified, CAP-accredited laboratories in Austin and San Carlos, California, Natera has processed more than 12 million tests and validated its technology through over 300 peer-reviewed publications. The company went public in 2015 and continues to innovate in precision medicine, aiming to make personalized genetic testing part of standard healthcare to enable earlier interventions and improved patient outcomes.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.